Published in Am J Respir Crit Care Med on July 12, 2012
Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med (2013) 3.02
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J (2014) 2.28
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data. Tuberculosis (Edinb) (2013) 2.10
Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2014) 1.74
Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study. Am J Respir Crit Care Med (2013) 1.21
Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression. Am J Respir Crit Care Med (2014) 1.06
Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township. J Infect Dis (2014) 1.01
Modeling tuberculosis in nonhuman primates. Cold Spring Harb Perspect Med (2014) 0.95
Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis. J Infect Dis (2013) 0.95
Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis. Front Immunol (2015) 0.91
Transforming the fight against tuberculosis: targeting catalysts of transmission. Clin Infect Dis (2014) 0.87
Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda. BMC Infect Dis (2014) 0.86
Development and Performance Evaluation of an Exhaled-Breath Bioaerosol Collector for Influenza Virus. Aerosol Sci Technol (2013) 0.83
Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings. Int J Tuberc Lung Dis (2016) 0.83
A Cough Aerosol Simulator for the Study of Disease Transmission by Human Cough-Generated Aerosols. Aerosol Sci Technol (2013) 0.78
Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis. BMC Infect Dis (2014) 0.78
Chest Radiographic Patterns and the Transmission of Tuberculosis: Implications for Automated Systems. PLoS One (2016) 0.77
Cough Aerosols of Mycobacterium tuberculosis in the Prediction of Incident Tuberculosis Disease in Household Contacts. Clin Infect Dis (2016) 0.77
Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics. PLoS One (2015) 0.76
A review of clinical models for the evaluation of human TB vaccines. Hum Vaccin Immunother (2016) 0.75
Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC). PLoS One (2016) 0.75
Contact Investigation: A Priority for Tuberculosis Control Programs. Am J Respir Crit Care Med (2016) 0.75
Face mask sampling for the detection of Mycobacterium tuberculosis in expelled aerosols. PLoS One (2014) 0.75
Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis. Sci Rep (2017) 0.75
Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages. Cell Cycle (2016) 0.75
Effect of diabetes on tuberculosis presentation and outcomes in Kiribati. Trop Med Int Health (2015) 0.75
Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis. F1000Res (2016) 0.75
Uniform-related infection control practices of dental students. Infect Drug Resist (2017) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (2006) 21.60
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med (1994) 16.32
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med (2000) 13.69
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet (1999) 10.06
Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A (1997) 9.07
Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep (2005) 8.91
Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle (1976) 4.53
Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis (1962) 4.15
Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet (2007) 3.65
Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med (2003) 2.82
A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr (2005) 2.47
Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax (2004) 2.34
Tuberculosis transmission in the 1990s. N Engl J Med (1994) 2.11
The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08
Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology (2002) 1.97
Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. Am Rev Respir Dis (1960) 1.87
Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax (2009) 1.78
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med (2011) 1.68
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis (1985) 1.56
Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. Am J Epidemiol (2001) 1.49
The pathogenicity of Mycobacterium tuberculosis during chemotherapy. Eur Respir J (1990) 1.48
Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infect Control Hosp Epidemiol (1997) 1.39
Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc (1975) 1.30
Insufficient quality of sputum submitted for tuberculosis diagnosis and associated factors, in Klaten district, Indonesia. BMC Pulm Med (2009) 1.16
Variability of airborne transmission of Mycobacterium tuberculosis: implications for control of tuberculosis in the HIV era. Clin Infect Dis (2007) 1.06
A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. Am Rev Respir Dis (1973) 1.06
Developing molecular amplification methods for rapid diagnosis of respiratory tract infections caused by bacterial pathogens. Clin Infect Dis (2011) 0.89
A new paradigm in respiratory hygiene: increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion. BMC Pulm Med (2005) 0.88
Editorial: Effect of chemotherapy on infectiousness of tuberculosis. N Engl J Med (1974) 0.84
Risk of tuberculosis in children from smear-negative source cases. Int J Tuberc Lung Dis (2005) 0.80
Tubercle bacilli retain pathogenicity after seven weeks chemotherapy. Med J Aust (1981) 0.79
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature (2009) 8.44
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med (2016) 6.22
Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc Natl Acad Sci U S A (2011) 4.55
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (2013) 4.26
Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr (2005) 4.19
Phase transitions in the assembly of multivalent signalling proteins. Nature (2012) 3.49
Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ (2010) 3.31
Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ (2007) 3.30
Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med (2011) 3.29
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Hierarchical regulation of WASP/WAVE proteins. Mol Cell (2008) 2.86
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (2006) 2.69
Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Am J Respir Crit Care Med (2003) 2.59
Obstacles to conducting epidemiological research in the UK general population. BMJ (2004) 2.59
Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis (2012) 2.51
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma. Blood (2010) 2.49
Ascertaining the size of the symptom iceberg in a UK-wide community-based survey. Br J Gen Pract (2011) 2.33
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis (2008) 2.26
Validation of the diagnosis of autism in general practitioner records. BMC Public Health (2004) 2.22
Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother (2005) 2.17
Anaplastic lymphoma kinase translocation: a predictive biomarker of pemetrexed in patients with non-small cell lung cancer. J Thorac Oncol (2011) 2.09
Use of antenatal services and delivery care in Entebbe, Uganda: a community survey. BMC Pregnancy Childbirth (2007) 2.08
Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. AIDS (2014) 2.05
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 2.04
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2010) 2.04
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med (2009) 2.03
Guidance on the management of pain in older people. Age Ageing (2013) 2.02
MMR vaccination and pervasive developmental disorders: a case-control study. Lancet (2004) 2.02
HIV risk perception and prevalence in a program for prevention of mother-to-child HIV transmission: comparison of women who accept voluntary counseling and testing and those tested anonymously. J Acquir Immune Defic Syndr (2005) 1.96
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis (2009) 1.92
CT-derived estimation of cochlear morphology and electrode array position in relation to word recognition in Nucleus-22 recipients. J Assoc Res Otolaryngol (2002) 1.91
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. Blood (2010) 1.89
NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res (2010) 1.87
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother (2010) 1.83
The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy. Genes Cancer (2010) 1.80
Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis (2004) 1.76
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ (2004) 1.76
Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 1.76
Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation. Vaccine (2007) 1.74
First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine (2008) 1.71
Burden of tuberculosis in Kampala, Uganda. Bull World Health Organ (2004) 1.69
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med (2011) 1.68
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis (2004) 1.67
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis (2010) 1.66
Associations between mild-to-moderate anaemia in pregnancy and helminth, malaria and HIV infection in Entebbe, Uganda. Trans R Soc Trop Med Hyg (2007) 1.66
Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer. Clin Cancer Res (2009) 1.65
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS (2004) 1.65
Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J Clin Microbiol (2007) 1.64
Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr (2014) 1.61
Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis (2007) 1.60
A cluster-randomised trial to compare home-based with health facility-based antiretroviral treatment in Uganda: study design and baseline findings. Open AIDS J (2007) 1.60
Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis (2002) 1.59
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis. Vaccine (2009) 1.59
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 1.58
Impact of chronic respiratory symptoms in a rural area of sub-Saharan Africa: an in-depth qualitative study in the Masindi district of Uganda. Prim Care Respir J (2013) 1.57
The incubation period of kuru. Epidemiology (2002) 1.56
Contact investigation for active tuberculosis among child contacts in Uganda. Clin Infect Dis (2013) 1.56
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives. Vaccine (2008) 1.55
Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda. PLoS One (2012) 1.52
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr (2013) 1.51
Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res (2011) 1.51
Enhanced specificity of the p53 family proteins-based adenoviral gene therapy in uterine cervical cancer cells with E2F1-responsive promoters. Cancer Biol Ther (2006) 1.46
Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs. Tuberculosis (Edinb) (2009) 1.45
Whole blood bactericidal activity during treatment of pulmonary tuberculosis. J Infect Dis (2003) 1.44
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Antimicrob Agents Chemother (2007) 1.44
Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol (2006) 1.44
Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women. Menopause (2012) 1.43
Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain (2009) 1.42
Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. J Infect Dis (2004) 1.42